Skip to main content
. 2022 Nov 15;12(11):5325–5341.

Table 6.

The significantly differential percentage of promoter methylation in tumor suppressor genes between serous type ovarian cancer tissues and non-serous type ovarian cancer tissues

Gene name Number of methylation/all (%) p-value

Group 1 Group 2
RASSF1A* 10/39 (26%) 34/71 (48%) 0.023
RASSF1A** 11/39 (28%) 36/71 (51%) 0.022
CDKN2A 4/39 (10%) 1/71 (1%) 0.033
BRCA1 11/39 (28%) 0/71 (0%) <0.001
SCGB3A1 3/39 (8%) 21/71 (30%) 0.008
ID4 1/39 (3%) 11/71 (15%) 0.038
CACNA1A 3/39 (8%) 24/71 (34%) 0.002

Note: *group 1: serous type epithelial ovarian cancer tissues; group 2: non-serous type epithelial ovarian cancer tissues;

*

probe 1: RASSF1A(328);

**

probe 2: RASSF1A: RASSF1A(382).